10X GENOMICS LTD

11771056
Active Counterslip

Other business support service activities n.e.c.

29 employees website.com
Life sciences and medical technology Other business support service activities n.e.c.
1

10X GENOMICS LTD

11771056

Other business support service activities n.e.c.

Founded 16 Jan 2019 Active Counterslip, United Kingdom 29 employees website.com
Life sciences and medical technology Other business support service activities n.e.c.
Accounts Submitted 18 Jul 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 7 Nov 2025 Next due 21 Nov 2026 5 months remaining
Net assets £3M £464K 2024 year on year
Total assets £4M £278K 2024 year on year
Total Liabilities £783K £185K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

C/O Bdo Bristol Bridgewater House Counterslip Bristol BS1 6BX United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for 10X GENOMICS LTD (11771056), an active life sciences and medical technology company based in Counterslip, United Kingdom. Incorporated 16 Jan 2019. Other business support service activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type small
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2019–2024)

Cash in Bank

£2.08M

Increased by £1.86M (+845%)

Net Assets

£3.31M

Increased by £463.74k (+16%)

Total Liabilities

£782.79k

Decreased by £185.37k (-19%)

Turnover

£5.61M

Decreased by £369.41k (-6%)

Employees

29

Increased by 2 (+7%)

Debt Ratio

19%

Decreased by 6 (-24%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active
Status
Bryant Ii, James Sears, Mr.DirectorAmericanUnited States396 Oct 2025Active
Eric Stewart WhitakerDirectorAmericanUnited States5916 Jan 2019Active

Shareholders

Shareholders (1)

10x Genomics Inc
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

10x Genomics, Inc.

United States Of America

Active
Notified 16 Jan 2019
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

10X GENOMICS LTD Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
7 Nov 2025Confirmation StatementConfirmation statement made on 7 Nov 2025 with no updates
14 Oct 2025OfficersAppointment of Mr. James Sears Bryant Ii as director on 6 Oct 2025
14 Oct 2025OfficersTermination of Eric Stewart Whitaker as director on 6 Oct 2025
18 Jul 2025AccountsAnnual accounts made up to 31 Dec 2024
8 Nov 2024Confirmation StatementConfirmation statement made on 7 Nov 2024 with no updates
7 Nov 2025 Confirmation Statement

Confirmation statement made on 7 Nov 2025 with no updates

14 Oct 2025 Officers

Appointment of Mr. James Sears Bryant Ii as director on 6 Oct 2025

14 Oct 2025 Officers

Termination of Eric Stewart Whitaker as director on 6 Oct 2025

18 Jul 2025 Accounts

Annual accounts made up to 31 Dec 2024

8 Nov 2024 Confirmation Statement

Confirmation statement made on 7 Nov 2024 with no updates

Recent Activity

Latest Activity

Confirmation statement made on 7 Nov 2025 with no updates

7 months ago on 7 Nov 2025

Appointment of Mr. James Sears Bryant Ii as director on 6 Oct 2025

8 months ago on 14 Oct 2025

Termination of Eric Stewart Whitaker as director on 6 Oct 2025

8 months ago on 14 Oct 2025

Annual accounts made up to 31 Dec 2024

11 months ago on 18 Jul 2025

Confirmation statement made on 7 Nov 2024 with no updates

1 years ago on 8 Nov 2024